Lupin Announces U.S. FDA Approval and Launch of Sugammadex Injection

Glenmark Pharmaceuticals Inc., USA launches Sugammadex Injection, 200 mg/2 mL (100 mg/mL) and 500 mg/5 mL (100 mg/mL) Single-Dose Vials

Gland Pharma receives FDA approval for Sugammadex injection, expected to boost sales and shares significantly.